Sleep-in workers not entitled to NMW for entire shift
A unanimous ruling by The Supreme Court in the Royal Mencap v Tomlinson-Blake and another case.
Amelia Goodwin quoted by People Management, Home Care Insight and Care Home Management on the implications of the Supreme Court's ruling in Royal Mencap Society v Tomlinson-Blake
The court found that care providers do not have to pay the minimum wage to staff for time that they are asleep but on call during shifts.
Pharmacy Brief - March 2021
The March edition of our Pharmacy Brief
The firm's role in advising Dentex on the acquisition of The Essex Smile Centre reported by Business Money
The sale of The Essex Smile Centre to Dentex Healthcare Group Limited has been completed.
Natalie Deuchar and Leonora Owens write for Pharmacy Business on the considerations to take into account when pharmacists look to obtain a new unit
Pharmacists should be aware of the law when considering obtaining a new unit.
Noel Wardle quoted by Chemist and Druggist on the issues that need to be considered before pharmacies adopt a hub-and-spoke dispensing model
Under current legislation, the hub-and-spoke model can be carried out by pharmacies owned by the same legal entity.
Claire Fallows writes for Planning Magazine on the proposed changes to permitted development rights to convert Class E to residential
According to government plans, certain properties will be able to convert to residential use without submission of a planning application.
Noel Wardle writes for Chemist and Druggist on whether pharmacy professionals can be sued for COVID vaccine negligence
Charles Russell Speechlys' Corporate team shortlisted for the 2021 South East Dealmakers Awards
Our Guildford team shortlisted at the Insider South East Dealmakers Awards 2021 for Corporate Law Firm of the Year.
Pharmacy Brief - December 2020
The December edition of our Pharmacy Brief
How do I amend an existing planning consent?
Reviewing the two main routes to a planning permission's amendment, once it is granted.
Charles Russell Speechlys advises Emergex Vaccines on $11m fundraising
Emergex is a UK-based biotechnology company and pioneers of developing synthetic ‘set point’ vaccines .
Public Company Update - November 2020
The November 2020 edition of our biannual Public Company Update.
Noel Wardle writes for Chemist and Druggist on how pharmacists can supply the COVID-19 vaccine lawfully
Claire Fallows quoted by Planning Magazine on the implications of the new permitted development rights for the UK planning system
Charles Russell Speechlys advises on sale of dental practice Feltham Dental
Feltham Dental was established in 1982, the business is an integral part of the community and has many generations of loyal patients.
Pei-Li Kew writes for P3 Pharmacy on the differences between share and asset transactions when buying a pharmacy
Noel Wardle writes for Pharmacy Business on whether a notice to close a pharmacy can be withdrawn
Helen Hutton writes for the Estates Gazette Legal Q&A on amending planning permission to meet changing demands
Noel Wardle writes for Chemist & Druggist on the downsides of the new MUR legislation